Article
Bisphosphonates induce apoptosis in CLL cells independently of MDR phenotype.
Cancer chemotherapy and pharmacology - 1 Jun 2008
Silva Karina Lani, Vasconcellos Deborah Vidal, Castro Eric Delfraro de Paula, Vasconcelos Flavia da Cunha, Bigni Ricardo, Maia Raquel Ciuvalschi
Abstract excerpt
PURPOSE: The anti-tumoral activity of bisphosphonates (BPs) has been reported in leukemia. In this study, we attempted to evaluate the apoptotic effects of the BPs pamidronate (PAM) and zoledronic acid (ZOL) in chronic lymphocytic leukemia (CLL) samples, and to correlate it with clinical parameters and multidrug resistance (MDR) phenotype (P-glycoprotein and multidrug resistance-related protein expression and/or...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
